ArticleUrology case reports2017
Angiosarcoma of the Adrenal Gland Treated Using a Multimodal Approach.
Article in Urology case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 14 citations in OpenAlex.
- Adrenal angiosarcoma, a rare neoplasm: a case report and a literature review.Gland surgery · 2026Article
- Spotlight on the Unusual: A Case Report of Adrenal Angiosarcoma Presenting as an Abdominal Mass.Cureus · 2025Article
- Recurrent fever leading to the diagnosis of an angiosarcoma of the adrenal gland: a case report.Journal of medical case reports · 2024Article
- Article
- Epithelioid angiosarcoma of the adrenal gland with metastasis: a case report and literature review.Annals of medicine and surgery (2012) · 2023Article
- A Rare Case of Primary Adrenal Epithelioid Angiosarcoma.The American journal of case reports · 2023Article
- Incidental adrenal hemangioma clinically suspicious for malignancy: diagnostic considerations and review of the literature.International journal of clinical and experimental pathology · 2022Article
- Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel.Frontiers in oncology · 2021Article
- Report of two rare cases of adrenal incidentalomas with different origins: revisiting pathological and radiological findings with a short review of the literature.Journal of the Egyptian National Cancer Institute · 2020Review
- Adrenal angiosarcoma with metastasis: Imaging and histopathology of a rare adrenal cancer.Radiology case reports · 2020Article
- Adrenal Angiosarcoma: A Diagnostic Dilemma.Cureus · 2019Article
- A case of angiosarcomas which occurred in an adrenal gland and spleen synchronously.International cancer conference journal · 2018Article
- A case report of primary adrenal angiosarcoma as depicted on magnetic resonance imaging.Medicine · 2017Article
- Primary Adrenal Angiosarcoma: A Rare and Potentially Misdiagnosed Tumor.Cancer control : journal of the Moffitt Cancer Center · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Angiosarcoma of the adrenal gland is an extremely rare malignancy. We report a case of a 59-year-old female who presented with abdominal pain and profound anemia. A 7 cm enhancing, lipid-poor adrenal mass with calcifications that extended posterior to the vena cava was identified on imaging. Patient underwent right adrenalectomy with retroperitoneal lymph node dissection. Pathology demonstrated angiosarcoma of the adrenal gland. Consolidative treatment included adjuvant radiation and chemotherapy. Patient remains disease free 1.5 years following treatment. Prior reported literature on the diagnosis and management of adrenal angiosarcoma is reviewed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.